PRIVATE & CONFIDENTIAL February 13, 2023 James B. Bucher [Redacted] [Redacted] Dear Jim,Transition, Separation and Consulting Agreement • March 28th, 2024 • Eliem Therapeutics, Inc. • Pharmaceutical preparations
This letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) that Eliem Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
September 2, 2021 Jay B. Saoud Groton, MA 01450 Re: Transition, Separation, and Consulting Agreement Dear Jay:Transition, Separation, and Consulting Agreement • September 8th, 2021 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Massachusetts
This letter sets forth the terms of the transition, separation, and consulting agreement (the “Agreement”) that Minerva Neurosciences, Inc. (the “Company”) is offering to you to aid in your transition.
Re: Transition, Separation and Consulting AgreementTransition, Separation and Consulting Agreement • January 9th, 2023 • Mirum Pharmaceuticals, Inc. • Pharmaceutical preparations
This letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) that Mirum Pharmaceuticals, Inc. (the “Company”) is offering to you.
TURNING POINT THERAPEUTICS, INC.Transition Separation and Consulting Agreement • January 9th, 2020 • Turning Point Therapeutics, Inc. • Pharmaceutical preparations • California
This letter sets forth the terms of the transition separation and consulting agreement (the “Agreement”) that Turning Point Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
ATARA BIOTHERAPEUTICS, INC.Transition, Separation and Consulting Agreement • August 12th, 2024 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
This letter sets forth the terms of the transition, separation and consulting agreement (this “Agreement”) that Atara Biotherapeutics, Inc. (the “Company”) is offering to you to aid in your voluntary resignation from the Company.
November 27, 2020Transition, Separation, and Consulting Agreement • May 10th, 2021 • Fibrogen Inc • Pharmaceutical preparations • California
August 13, 2023 Christopher Stewart Re: Transition, Separation, and Consulting Agreement Dear Chris:Transition, Separation, and Consulting Agreement • November 8th, 2023 • Bionano Genomics, Inc. • Laboratory analytical instruments
This letter sets forth the substance of the separation and consulting agreement (the “Agreement”) that Bionano Genomics, Inc. (the “Company”) is offering to you to aid in your employment transition.
September 11, 2019 Via Hand Delivery Greg Went c/o Adamas Pharmaceuticals, Inc. Re: Transition, Separation, and Consulting Agreement Dear Greg:Transition, Separation, and Consulting Agreement • November 7th, 2019 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • California
This letter sets forth the substance of the transition, separation, and consulting agreement (the “Agreement”) that Adamas Pharmaceuticals, Inc. (the “Company”) is offering to you to aid in your employment transition.
March 26, 2021 Norman Greenberg 12625 High Meadow Road North Potomac, MD 20878 Re:Transition Separation and Consulting Agreement Dear Norm:Transition Separation and Consulting Agreement • May 12th, 2021 • Atreca, Inc. • Pharmaceutical preparations • California
This letter sets forth the substance of the transition separation and consulting agreement (the “Agreement”) that Atreca, Inc. (the “Company”) is offering to you to aid in your employment transition.
February 2, 2022 Vineet R. Jindal 5521 Linmore Lane Plano, TX 75093 Re:Transition, Separation and Consulting AgreementTransition, Separation and Consulting Agreement • March 23rd, 2022 • Reneo Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) that Reneo Pharmaceuticals, Inc. (the “Company”) is offering to you to aid in your employment transition.
Re:Transition, Separation and Consulting AgreementTransition, Separation and Consulting Agreement • March 30th, 2022 • Metacrine, Inc. • Pharmaceutical preparations • California
This letter sets forth the substance of the transition and separation agreement (the “Agreement”) that Metacrine, Inc. (the “Company”) is offering to you.
